David Andersen has represented a variety of companies, individuals, private equity funds and institutional clients in general corporate and securities matters, with an emphasis on the representation of emerging-growth high-technology and biotechnology companies.  In this capacity, Mr. Andersen has assisted clients in structuring, developing and positioning numerous business enterprises for venture capital investment, growth through acquisitions and eventual sale or initial public offerings.

Mr. Andersen’s practice includes counseling clients in connection with issues related to initial formation and capitalization, public and private offerings of debt and equity securities, including venture capital financing, technology transactions and strategic alliances, stock and asset acquisitions, mergers and consolidations and joint ventures.  In addition, Mr. Andersen has represented a number of public companies in diverse industries (including technology, healthcare, manufacturing, entertainment and lodging) in all aspects of securities reporting and compliance, and advises clients with respect to a wide range of corporate governance issues, including stock option and stock purchase plans and related matters.

Representative Experience

• Numerous acquisitions and sales of public and private companies in industries such as software, hardware, telecom, IT services, biotechnology and entertainment and new media
• Representing a manufacturing company in a cross-border restructuring, business combination and syndicated credit facility
• Representing a medical group in a restructuring and spin-off transaction with a hospital chain
• Representing the issuers and venture capital firms in numerous private placement financings in the technology, Internet and biotechnology industries
• Representing the issuer in a $100 million venture capital investment and recapitalization transaction
• Representing a party to a merger of publicly traded healthcare companies and with respect to the related S-4 registration statement
• Serving as issuer’s counsel in the initial public offering of a technology company
• Serving as issuer’s counsel in Rule 144A offerings and in secondary public offerings